EP 3525811 A1 20190821 - HEMOSTATIC PRODUCTS
Title (en)
HEMOSTATIC PRODUCTS
Title (de)
HÄMOSTATIKA
Title (fr)
PRODUITS HÉMOSTATIQUES
Publication
Application
Priority
- US 201662406783 P 20161011
- US 2017056062 W 20171011
Abstract (en)
[origin: US2018099069A1] A hemostatic product that includes a fibrinogen mixture, a thrombin mixture and a biologically tolerable liquid. The fibrinogen mixture includes fibrinogen and at least one fibrinogen stabilizer. The thrombin mixture includes thrombin and at least one thrombin stabilizer. The biologically tolerable liquid is mixed with the fibrinogen mixture and the thrombin mixture to form the hemostatic product.
IPC 8 full level
A61K 38/36 (2006.01); A61L 15/38 (2006.01); A61L 15/44 (2006.01)
CPC (source: EP US)
A61L 15/32 (2013.01 - US); A61L 15/38 (2013.01 - US); A61L 26/0042 (2013.01 - EP US); A61L 26/0052 (2013.01 - EP US); A61L 2300/254 (2013.01 - US); A61L 2300/418 (2013.01 - EP US); A61L 2400/04 (2013.01 - EP US)
C-Set (source: EP US)
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
DOCDB simple family (publication)
US 2018099069 A1 20180412; AU 2017344082 A1 20190314; CA 3033757 A1 20180419; EP 3525811 A1 20190821; EP 3525811 A4 20200527; WO 2018071488 A1 20180419
DOCDB simple family (application)
US 201715729934 A 20171011; AU 2017344082 A 20171011; CA 3033757 A 20171011; EP 17859998 A 20171011; US 2017056062 W 20171011